Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $12.87B | 108,098,397 | 0.04% | 99.96% | Net Buying | Net Selling | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $32.46B | 133,809,118 | 0.10% | 20.79% | Net Selling | Net Selling | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $6.30B | 78,024,013 | 0.06% | 10.38% | Net Selling | Net Selling | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $3.33B | 125,691,961 | 0.10% | 30.69% | Net Selling | Net Selling | ||
| ADMA | ADMA BIOLOGICS INC | $2.25B | 223,984,680 | 0.09% | 25.11% | Net Selling | Net Buying | ||
| HALO | HALOZYME THERAPEUTICS INC | $12.21B | 113,498,000 | 0.11% | 30.26% | Net Selling | Net Selling | ||
| VCEL | VERICEL CORP | $2.23B | 51,206,614 | 0.11% | 10.19% | Net Selling | Net Selling | ||
| KRYS | KRYSTAL BIOTECH INC | $10.16B | 29,598,836 | 0.10% | 24.37% | Net Selling | Net Selling | ||
| RPRX | ROYALTY PHARMA PLC | $35.49B | 575,001,204 | 0.06% | 18.01% | Net Selling | Net Selling | ||
| TGTX | TG THERAPEUTICS INC | $7.91B | 153,069,053 | 0.07% | 48.65% | Net Selling | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $720.33M | 59,383,781 | 0.08% | 21.68% | Net Selling | Net Selling | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $13.42B | 193,573,759 | 0.10% | 1.81% | Net Selling | |||
| NAGE | NIAGEN BIOSCIENCE INC | $250.83M | 79,126,002 | 0.02% | 99.98% | Net Buying | Net Buying | ||
| LGND | LIGAND PHARMACEUTICALS INC | $5.80B | 19,935,609 | 0.02% | 99.98% | Net Selling | Net Selling | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $139.93B | 253,460,924 | 0.10% | 1.52% | Net Selling | Net Selling | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $16.37B | 64,914,577 | 0.04% | 99.96% | Net Selling | Net Selling | ||
| SPRO | SPERO THERAPEUTICS INC | $71.63M | 58,234,827 | 0.04% | 62.43% | Net Selling | |||
| TECH | BIO-TECHNE CORP | $11.35B | 156,568,751 | 0.11% | 2.54% | Net Selling | Net Selling | ||
| MDXG | MIMEDX GROUP INC | $648.63M | 145,760,468 | 0.08% | 83.43% | Net Buying | Net Buying | ||
| EXEL | EXELIXIS INC | $13.48B | 247,781,692 | 0.10% | 5.67% | Net Selling | Net Selling | ||
| UTHR | UNITED THERAPEUTICS CORP | $22.70B | 42,890,692 | 0.10% | 14.82% | Net Selling | Net Buying | ||
| REGN | REGENERON PHARMACEUTICALS INC | $86.57B | 102,954,988 | 0.09% | 39.26% | Net Selling | Net Selling | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.33B | 58,236,393 | 0.09% | 25.53% | Net Selling | |||
| INCY | INCYTE CORP | $26.04B | 202,697,746 | 0.10% | 28.09% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.